Early results look good in Pfizer COVID vaccine trial, what does that mean?


With the announcement of a coronavirus vaccine from Pfizer getting good results in trials, then followed by news that the FDA is allowing emergency use of the first antibody drug to fight COVID-19, there is a lot of excitement that we may finally be turning the corner on this pandemic.

To put this into perspective, Shelley Kirk talked with Thomas Dyzynski, Director of epidemiology education at IUPUI.

For the latest breaking news and stories from across the
Tri-State, follow Eyewitness News on Facebook and Twitter.

(This story was originally published on Nov. 10, 2020)\


Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories